LS Investment Advisors LLC reduced its position in shares of Omnicell, Inc. (NASDAQ:OMCL) by 0.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,543 shares of the company’s stock after selling 28 shares during the period. LS Investment Advisors LLC’s holdings in Omnicell were worth $153,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently made changes to their positions in OMCL. Monroe Bank & Trust MI increased its stake in shares of Omnicell by 0.3% in the first quarter. Monroe Bank & Trust MI now owns 34,831 shares of the company’s stock worth $1,416,000 after buying an additional 116 shares in the last quarter. State of Alaska Department of Revenue increased its stake in shares of Omnicell by 3.0% in the first quarter. State of Alaska Department of Revenue now owns 4,080 shares of the company’s stock worth $165,000 after buying an additional 120 shares in the last quarter. Texas Permanent School Fund increased its stake in shares of Omnicell by 0.5% in the first quarter. Texas Permanent School Fund now owns 26,756 shares of the company’s stock worth $1,088,000 after buying an additional 122 shares in the last quarter. Municipal Employees Retirement System of Michigan increased its stake in shares of Omnicell by 2.6% in the first quarter. Municipal Employees Retirement System of Michigan now owns 8,340 shares of the company’s stock worth $339,000 after buying an additional 210 shares in the last quarter. Finally, 1st Global Advisors Inc. increased its stake in shares of Omnicell by 3.4% in the first quarter. 1st Global Advisors Inc. now owns 7,828 shares of the company’s stock worth $318,000 after buying an additional 255 shares in the last quarter. Institutional investors and hedge funds own 96.35% of the company’s stock.

Shares of Omnicell, Inc. (NASDAQ OMCL) traded down 1.69% during mid-day trading on Thursday, reaching $49.30. 97,973 shares of the company’s stock traded hands. The company has a 50 day moving average of $45.01 and a 200 day moving average of $40.99. The company’s market cap is $1.85 billion. Omnicell, Inc. has a 12 month low of $30.35 and a 12 month high of $51.98.

Omnicell (NASDAQ:OMCL) last posted its quarterly earnings results on Thursday, July 27th. The company reported $0.02 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.02. The firm had revenue of $180.90 million for the quarter, compared to analysts’ expectations of $174.08 million. Omnicell had a positive return on equity of 0.41% and a negative net margin of 1.14%. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.38 EPS. Analysts expect that Omnicell, Inc. will post $1.31 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “LS Investment Advisors LLC Has $153,000 Position in Omnicell, Inc. (OMCL)” was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another site, it was copied illegally and reposted in violation of U.S. and international copyright and trademark laws. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/ls-investment-advisors-llc-has-153000-position-in-omnicell-inc-omcl/1471151.html.

A number of analysts recently weighed in on the stock. Dougherty & Co increased their price target on shares of Omnicell from $45.00 to $49.00 and gave the company a “buy” rating in a research report on Friday, July 28th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $47.00 price target (up from $43.00) on shares of Omnicell in a research report on Tuesday, June 13th. Oppenheimer Holdings, Inc. reiterated an “outperform” rating and issued a $53.00 price target (up from $43.00) on shares of Omnicell in a research report on Tuesday, April 25th. Piper Jaffray Companies downgraded shares of Omnicell from an “overweight” rating to a “neutral” rating and set a $40.00 price target on the stock. in a research report on Friday, April 21st. Finally, TheStreet downgraded shares of Omnicell from a “b-” rating to a “c+” rating in a research report on Thursday, May 4th. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $49.00.

In other news, EVP Dan S. Johnston sold 16,400 shares of the company’s stock in a transaction that occurred on Friday, May 19th. The stock was sold at an average price of $40.67, for a total transaction of $666,988.00. Following the transaction, the executive vice president now directly owns 61,696 shares of the company’s stock, valued at $2,509,176.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Chairman Randall A. Lipps sold 40,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 1st. The stock was sold at an average price of $49.76, for a total value of $1,990,400.00. Following the transaction, the chairman now directly owns 196,551 shares in the company, valued at $9,780,377.76. The disclosure for this sale can be found here. Insiders have sold 199,823 shares of company stock worth $9,301,391 over the last ninety days. 3.77% of the stock is owned by insiders.

About Omnicell

Omnicell, Inc provides automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. It operates through two segments: Automation and Analytics, and Medication Adherence.

Want to see what other hedge funds are holding OMCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omnicell, Inc. (NASDAQ:OMCL).

Institutional Ownership by Quarter for Omnicell (NASDAQ:OMCL)

Receive News & Ratings for Omnicell Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.